IL114948A0 - A transdermal therapeutic system containing estradiol and a process for the preparation thereof - Google Patents
A transdermal therapeutic system containing estradiol and a process for the preparation thereofInfo
- Publication number
- IL114948A0 IL114948A0 IL11494895A IL11494895A IL114948A0 IL 114948 A0 IL114948 A0 IL 114948A0 IL 11494895 A IL11494895 A IL 11494895A IL 11494895 A IL11494895 A IL 11494895A IL 114948 A0 IL114948 A0 IL 114948A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic system
- transdermal therapeutic
- preparation
- system containing
- containing estradiol
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title abstract 2
- 229930182833 estradiol Natural products 0.000 title abstract 2
- 229960005309 estradiol Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 4
- 239000000654 additive Substances 0.000 abstract 2
- 230000000996 additive effect Effects 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 239000010410 layer Substances 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Auxiliary Drives, Propulsion Controls, And Safety Devices (AREA)
- Traffic Control Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention concerns a transdermal therapeutic system which contains oestradiol as active substance and optionally further active substances as well as a hydrophylic additive. The therapeutic system has a layered structure comprising a backing which is impervious to the active substances and moisture, an active substance-containing matrix layer and, depending on the case, a separable protective layer. The system is characterized in that the hydrophylic additive is a component of the matrix.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4429664A DE4429664C2 (en) | 1994-08-20 | 1994-08-20 | Estradiol TTS with water-binding additives and process for its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL114948A0 true IL114948A0 (en) | 1995-12-08 |
| IL114948A IL114948A (en) | 2000-10-31 |
Family
ID=6526229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11494895A IL114948A (en) | 1994-08-20 | 1995-08-15 | Transdermal therapeutic system containing estradiol and process for the preparation thereof |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0776197B1 (en) |
| JP (1) | JPH10504314A (en) |
| KR (1) | KR100374476B1 (en) |
| CN (1) | CN1073413C (en) |
| AT (1) | ATE173163T1 (en) |
| AU (1) | AU700119B2 (en) |
| CA (1) | CA2197865C (en) |
| CZ (1) | CZ50897A3 (en) |
| DE (2) | DE4429664C2 (en) |
| DK (1) | DK0776197T3 (en) |
| ES (1) | ES2126308T3 (en) |
| FI (1) | FI118721B (en) |
| HU (1) | HUT77093A (en) |
| IL (1) | IL114948A (en) |
| NO (1) | NO970553D0 (en) |
| NZ (1) | NZ291449A (en) |
| PL (1) | PL180943B1 (en) |
| SI (1) | SI0776197T1 (en) |
| SK (1) | SK280299B6 (en) |
| WO (1) | WO1996005815A1 (en) |
| ZA (1) | ZA956926B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19600347A1 (en) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Skin-adhering pharmaceutical preparation, in particular TTS for the delivery of 17-beta-estradiol to the human organism |
| US6623763B2 (en) | 1996-01-08 | 2003-09-23 | Lts Lohmann Therape-System Ag | Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism |
| GB9720470D0 (en) | 1997-09-25 | 1997-11-26 | Ethical Pharmaceuticals South | Inhibition of crystallization in transdermal devices |
| DE19827732A1 (en) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6712090A (en) * | 1989-10-13 | 1991-05-16 | Watson Laboratories, Inc. | Drug delivery systems and matrix therefor |
| DE4223360C1 (en) * | 1992-07-16 | 1993-04-08 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| DE4237453C1 (en) * | 1992-11-06 | 1993-08-19 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| DE4309830C1 (en) * | 1993-03-26 | 1994-05-05 | Lohmann Therapie Syst Lts | Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer |
-
1994
- 1994-08-20 DE DE4429664A patent/DE4429664C2/en not_active Expired - Fee Related
-
1995
- 1995-08-12 JP JP8507755A patent/JPH10504314A/en active Pending
- 1995-08-12 DE DE59504233T patent/DE59504233D1/en not_active Expired - Lifetime
- 1995-08-12 SI SI9530203T patent/SI0776197T1/en unknown
- 1995-08-12 CZ CZ97508A patent/CZ50897A3/en unknown
- 1995-08-12 CA CA002197865A patent/CA2197865C/en not_active Expired - Fee Related
- 1995-08-12 KR KR1019970701107A patent/KR100374476B1/en not_active Expired - Fee Related
- 1995-08-12 AT AT95929104T patent/ATE173163T1/en active
- 1995-08-12 HU HU9701725A patent/HUT77093A/en unknown
- 1995-08-12 ES ES95929104T patent/ES2126308T3/en not_active Expired - Lifetime
- 1995-08-12 NZ NZ291449A patent/NZ291449A/en unknown
- 1995-08-12 WO PCT/EP1995/003202 patent/WO1996005815A1/en active IP Right Grant
- 1995-08-12 EP EP95929104A patent/EP0776197B1/en not_active Expired - Lifetime
- 1995-08-12 DK DK95929104T patent/DK0776197T3/en active
- 1995-08-12 AU AU32583/95A patent/AU700119B2/en not_active Ceased
- 1995-08-12 CN CN95194678A patent/CN1073413C/en not_active Expired - Fee Related
- 1995-08-12 SK SK219-97A patent/SK280299B6/en unknown
- 1995-08-15 IL IL11494895A patent/IL114948A/en not_active IP Right Cessation
- 1995-08-18 ZA ZA956926A patent/ZA956926B/en unknown
-
1997
- 1997-02-06 NO NO970553A patent/NO970553D0/en not_active Application Discontinuation
- 1997-02-18 PL PL95319014A patent/PL180943B1/en unknown
- 1997-02-19 FI FI970702A patent/FI118721B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU700119B2 (en) | 1998-12-24 |
| EP0776197A1 (en) | 1997-06-04 |
| DK0776197T3 (en) | 1999-07-26 |
| PL180943B1 (en) | 2001-05-31 |
| NO970553L (en) | 1997-02-06 |
| WO1996005815A1 (en) | 1996-02-29 |
| PL319014A1 (en) | 1997-07-21 |
| CN1155836A (en) | 1997-07-30 |
| ATE173163T1 (en) | 1998-11-15 |
| CN1073413C (en) | 2001-10-24 |
| NO970553D0 (en) | 1997-02-06 |
| SI0776197T1 (en) | 1999-04-30 |
| KR100374476B1 (en) | 2003-04-23 |
| CA2197865A1 (en) | 1996-02-29 |
| DE4429664C2 (en) | 1997-09-11 |
| CZ50897A3 (en) | 1997-06-11 |
| FI970702L (en) | 1997-02-19 |
| FI970702A0 (en) | 1997-02-19 |
| NZ291449A (en) | 1998-09-24 |
| IL114948A (en) | 2000-10-31 |
| CA2197865C (en) | 2005-10-25 |
| EP0776197B1 (en) | 1998-11-11 |
| KR970705380A (en) | 1997-10-09 |
| HUT77093A (en) | 1998-03-02 |
| DE4429664A1 (en) | 1996-02-22 |
| JPH10504314A (en) | 1998-04-28 |
| MX9701301A (en) | 1998-05-31 |
| SK21997A3 (en) | 1997-07-09 |
| DE59504233D1 (en) | 1998-12-17 |
| FI118721B (en) | 2008-02-29 |
| SK280299B6 (en) | 1999-11-08 |
| ZA956926B (en) | 1996-03-25 |
| AU3258395A (en) | 1996-03-14 |
| ES2126308T3 (en) | 1999-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2010218A1 (en) | Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances | |
| IE800059L (en) | Polymeric diffusion matrix | |
| IL106512A (en) | Plaster for the transdermal application of steroid hormones and process for the preparation thereof | |
| HRP930991B1 (en) | Transdermal therapeutic system containing the active substance 17-beta estradiol (anhydrous) | |
| IL114948A (en) | Transdermal therapeutic system containing estradiol and process for the preparation thereof | |
| MX9701302A (en) | Oestradiol transdermal therapeutic system comprising hygroscopic additives. | |
| IL124538A (en) | Transdermal delivery system for pharmaceutical compositions and a process for the preparation thereof | |
| CA2197867A1 (en) | Oestradiol transdermal therapeutic system comprising hygroscopic additives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |